Please assess the completion status of the following clinical trial:

Trial Title: Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Dutch or English speaking adults~* 18 years or older ASA I-III physical class~* Scheduled for elective arthroscopic shoulder surgery~Exclusion Criteria:~* History of allergy to a local anesthetic~* Baseline neurological deficit~* Medical condition that would make it difficult to assess sensory distribution or communicate with the investigators' staff~* Recent history (\< 3 months) of drug or alcohol abuse~* Concomitant opioid therapy~* Preexisting coagulation disorder~* Infection at the injection site~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Exparel block in arthroscopic surgery (Type: EXPERIMENTAL): Evaluation of Exparel block in arthroscopic shoulder surgery.
- Bupivacaine block in shoulder surgery (Type: EXPERIMENTAL): Evaluation of Bupivacaine block in shoulder surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).